Clinical heterogeneity in patients with the hypermobility type of Ehlers-Danlos Syndrome

被引:62
作者
De Wandele, Inge [1 ]
Rombaut, Lies [1 ]
Malfait, Fransiska [2 ]
De Backer, Tine [3 ]
De Paepe, Anne [2 ]
Calders, Patrick [1 ]
机构
[1] Univ Ghent, Dept Rehabil Sci & Physiotherapy, Artevelde Univ Coll, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium
[3] Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium
关键词
Ehlers-Danlos syndrome; Hypermobility; Clinical heterogeneity; Non-musculoskeletal symptoms; Functional impairment; Pain experience; MULTIDIMENSIONAL PAIN INVENTORY; QUALITY-OF-LIFE; SICKNESS IMPACT PROFILE; DYSFUNCTION; COMPLAINTS; REVISION; FATIGUE; VERSION;
D O I
10.1016/j.ridd.2012.11.018
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
EDS-HT is a connective tissue disorder characterized by large inter-individual differences in the clinical presentation, complicating diagnosis and treatment. We aim to describe the clinical heterogeneity and to investigate whether differences in the symptom profile are also reflected as disparity in functional impairment and pain experience. In this study, 78 patients were asked to describe their symptoms due to EDS-HT. Next, a hierarchical cluster analysis was performed using the Jaccard measure of similarity to assess whether subgroups could be distinguished based on the symptoms reported. This analysis yielded 3 clusters of participants with distinct complaint profiles. The key differences were found in the domain of non-musculoskeletal complaints, which was significantly larger in cluster 2. Furthermore, cluster 2 was characterized by a worse physical and psychosocial health, a higher pain severity and a larger pain interference in daily life. The results emphasize that non-musculoskeletal symptoms are an important complication of EDS-HT, as the number of these complaints was found to be a significant predictor for both functional health status (SIP) and pain experience (MPI). In conclusion, this study confirms that EDS-HT is a heterogeneous entity and encourages the clinician to be more aware of the large variety of EDS-HT symptoms, in order to improve disease recognition and to establish more tailored treatment strategies. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:873 / 881
页数:9
相关论文
共 33 条
  • [1] [Anonymous], 2012, WHOS PAIN LADD
  • [2] Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO
  • [3] 2-O
  • [4] THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE
    BERGNER, M
    BOBBITT, RA
    CARTER, WB
    GILSON, BS
    [J]. MEDICAL CARE, 1981, 19 (08) : 787 - 805
  • [5] Natural History and Manifestations of the Hypermobility Type Ehlers-Danlos Syndrome: A Pilot Study on 21 Patients
    Castori, Marco
    Camerota, Filippo
    Celletti, Claudia
    Danese, Chiara
    Santilli, Valter
    Saraceni, Vincenzo Maria
    Grammatico, Paola
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (03) : 556 - 564
  • [6] A FRENCH VERSION OF THE SICKNESS IMPACT PROFILE (SIP) - STAGES IN THE CROSS-CULTURAL VALIDATION OF A GENERIC QUALITY-OF-LIFE SCALE
    CHWALOW, AJ
    LURIE, A
    BEAN, K
    DUCHATELET, IP
    VENOT, A
    DUSSER, D
    DOUOT, Y
    STRAUCH, G
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1992, 6 (07) : 319 - 326
  • [7] Modulation of immune cell function by the autonomic nervous system
    Friedman, EM
    Irwin, MR
    [J]. PHARMACOLOGY & THERAPEUTICS, 1997, 74 (01) : 27 - 38
  • [8] Dysautonomia in the joint hypermobility syndrome
    Gazit, Y
    Nahir, AM
    Grahame, R
    Jacob, G
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01) : 33 - 40
  • [9] Hypermobility: an important but often neglected area within rheumatology
    Grahame, Rodney
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (10): : 522 - 524
  • [10] Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction?
    Hakim, AJ
    Grahame, R
    [J]. RHEUMATOLOGY, 2004, 43 (09) : 1194 - 1195